NEWS - Dec 14, 2021 Relmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option Read more
NEWS - Dec 8, 2021 Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common Stock Read more
NEWS - Dec 1, 2021 Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology Read more
NEWS - Nov 11, 2021 Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results Read more
NEWS - Nov 9, 2021 Relmada Therapeutics to Present at the Jefferies London Healthcare Conference Read more
NEWS - Nov 4, 2021 Relmada Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021 Read more
NEWS - Oct 29, 2021 Relmada Therapeutics to Present Data at the Neuroscience Education Institute Congress Read more
NEWS - Oct 4, 2021 Relmada Therapeutics Provides Regulatory and Development Updates on Ongoing Late-Stage Clinical Program for REL-1017 for Treatment of Major Depressive Disorder Read more
NEWS - Sep 17, 2021 Relmada Therapeutics to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Read more
